ADMA Biologics Inc

Stock Chart, Company Information, and Scan Results

$16.75(as of Aug 7, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

ADMA Biologics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$16.75
Ticker SymbolADMA
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees685
CountyUSA
Market Cap$4,426.1M

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

ADMA Biologics Inc In Our Stock Scanner

As of Aug 08, 2025
As of ---
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
example chart graphic
Scan Name: Death CrossScan Type: Stock Indicator Scans
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.